A tripeptide corresponding to the C-terminal sequence Lys-Pro-Val associated with α-MSH biology. Research interest centres on cellular signalling involved in inflammatory and immune-regulatory processes.
| Title |
|---|
| 4 vials (15% discount) |
| 8 vials (25% discount) |
| 12 vials (35% disocunt) |
KPV (Lysine-Proline-Valine) is a synthetic tripeptide derived from the C-terminal amino acid sequence of alpha-melanocyte-stimulating hormone (α-MSH). It has been investigated for its potential involvement in inflammatory regulation, immune signaling and epithelial tissue protection.
KPV has been studied in preclinical research examining inflammatory responses, particularly in experimental models of intestinal inflammation and epithelial barrier dysfunction. Laboratory studies suggest that it may influence inflammatory signaling pathways, including nuclear factor-kappa B (NF-κB), which plays an important role in regulating inflammatory gene expression.
Additional research has explored KPV’s interactions with intestinal epithelial cells, immune-associated pathways and inflammatory mediators. Its biological activity has generated scientific interest in the relationship between melanocortin-derived peptides and cellular inflammatory responses.
KPV 10 mg is presented as an experimental research peptide for laboratory and scientific applications. The stated quantity refers to the amount of peptide contained in the product and should not be interpreted as a recommended human dosage.
Product: KPV
Strength: 10 mg
Alternative name: Lysine-Proline-Valine
Category: Recovery
Compound classification: Synthetic melanocortin-derived tripeptide
Research target: Inflammatory signaling pathways, including NF-κB-associated cellular responses
Research focus: Inflammatory regulation, intestinal epithelial biology, immune signaling and tissue protection
Mechanism: Investigated for its potential modulation of NF-κB activation, inflammatory mediator production and epithelial inflammatory responses.
Intended use: Laboratory and research use only
WOLVERINE is a multi-peptide research formulation of BPC-157 and TB-500. These peptides are individually investigated for their involvement in tissue repair, cellular migration, inflammatory signaling and extracellular matrix remodeling.
Associated with Thymosin Beta-4, a naturally occurring peptide involved in tissue repair, wound healing and cellular regeneration. Research explores its role in cell migration, blood vessel formation (angiogenesis), inflammatory regulation and tissue remodeling, including recovery in muscle, tendon, skin and cardiovascular tissue.
A combined formulation intended for studying multiple signalling components within one experimental system, BPC-157 + TB-500 + GHK-Cu + KPV blend.
A multi-component research formulation combining peptides associated with cellular repair, extracellular-matrix signalling and tissue-remodelling research. The final page should identify every component and its exact amount rather than marketing GLOW as a single molecular entity.
A synthetic 15-amino-acid peptide extensively investigated in preclinical models involving cellular protection, vascular signalling and tissue-repair biology. Despite considerable experimental interest, human clinical evidence remains limited and no approved therapeutic formulation exists.
A synthetic peptide derived from the helix-B region of erythropoietin (EPO), investigated for tissue-protective signalling without reproducing EPO’s erythropoietic activity. Its research landscape includes inflammatory regulation, cellular protection and tissue-repair signalling pathways.